The variable use of heparin through intravenous bolus and flush fluid systems during endovascular stroke treatment, a world-wide survey
Abstract Background The total amount of heparin administered through flush fluids in stroke patients is not considered in recent trials, possibly influencing main results. We investigated the use of heparin among treating physicians worldwide. Methods We conducted a survey from November 2022 to Janu...
Saved in:
| Main Authors: | Senta Frol, Faysal Benali, Aymeric Rouchaud, Robrecht R. M. M. Knapen, Wim H. van Zwam, Research Committee of the European Society of Minimally Invasive Neurological Therapy (ESMINT) |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SpringerOpen
2025-03-01
|
| Series: | CVIR Endovascular |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s42155-025-00532-3 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Heparin-induced thrombocytopenia in a hemodialysis patient
by: YE Wei-xiang, et al.
Published: (2019-01-01) -
The effects of heparinized normal saline flushing and prophylactic enoxaparin on central venous catheter thrombosis in PICU hospitalized pediatric
by: Maryam Mohebbi, et al.
Published: (2024-07-01) -
Heparin, Heparin-like Molecules, and Heparin Mimetics in Breast Cancer: A Concise Review
by: Diego R. Gatica Portillo, et al.
Published: (2025-07-01) -
Multifaceted role of heparin in oncology: from anticoagulation to anticancer mechanisms and clinical implications
by: Niranjan Koirala, et al.
Published: (2025-02-01) -
Expanding the Role of Heparin Derivatives in Oncology: From Anticoagulation to Antitumor Activity
by: Jasmine Holail, et al.
Published: (2025-03-01)